CN106954854A - 一种具有保护视力缓解疲劳功能的组合物及其制备方法和应用 - Google Patents
一种具有保护视力缓解疲劳功能的组合物及其制备方法和应用 Download PDFInfo
- Publication number
- CN106954854A CN106954854A CN201710219002.3A CN201710219002A CN106954854A CN 106954854 A CN106954854 A CN 106954854A CN 201710219002 A CN201710219002 A CN 201710219002A CN 106954854 A CN106954854 A CN 106954854A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- composition
- present
- preparation
- relieving function
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 29
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 230000004438 eyesight Effects 0.000 title claims abstract description 13
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 claims abstract description 18
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims abstract description 15
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims abstract description 14
- 239000000843 powder Substances 0.000 claims abstract description 12
- 229940107666 astragalus root Drugs 0.000 claims abstract description 11
- 235000020733 paullinia cupana extract Nutrition 0.000 claims abstract description 9
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229960003512 nicotinic acid Drugs 0.000 claims abstract description 8
- 235000001968 nicotinic acid Nutrition 0.000 claims abstract description 7
- 239000011664 nicotinic acid Substances 0.000 claims abstract description 7
- 235000019161 pantothenic acid Nutrition 0.000 claims abstract description 7
- 239000011713 pantothenic acid Substances 0.000 claims abstract description 7
- 229940055726 pantothenic acid Drugs 0.000 claims abstract description 7
- 235000010447 xylitol Nutrition 0.000 claims abstract description 7
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims abstract description 6
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims abstract description 6
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000000811 xylitol Substances 0.000 claims abstract description 6
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims abstract description 6
- 229960002675 xylitol Drugs 0.000 claims abstract description 6
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims abstract description 4
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims abstract description 4
- 229930003451 Vitamin B1 Natural products 0.000 claims abstract description 4
- 229930003779 Vitamin B12 Natural products 0.000 claims abstract description 4
- 229930003471 Vitamin B2 Natural products 0.000 claims abstract description 4
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims abstract description 4
- 229960002477 riboflavin Drugs 0.000 claims abstract description 4
- 229960003495 thiamine Drugs 0.000 claims abstract description 4
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims abstract description 4
- 235000010374 vitamin B1 Nutrition 0.000 claims abstract description 4
- 239000011691 vitamin B1 Substances 0.000 claims abstract description 4
- 235000019163 vitamin B12 Nutrition 0.000 claims abstract description 4
- 239000011715 vitamin B12 Substances 0.000 claims abstract description 4
- 235000019164 vitamin B2 Nutrition 0.000 claims abstract description 4
- 239000011716 vitamin B2 Substances 0.000 claims abstract description 4
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 3
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 3
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims abstract description 3
- 235000019158 vitamin B6 Nutrition 0.000 claims abstract description 3
- 239000011726 vitamin B6 Substances 0.000 claims abstract description 3
- 229940011671 vitamin b6 Drugs 0.000 claims abstract description 3
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 claims description 6
- 229960001948 caffeine Drugs 0.000 claims description 6
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 claims description 6
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims description 5
- 235000013734 beta-carotene Nutrition 0.000 claims description 5
- 239000011648 beta-carotene Substances 0.000 claims description 5
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims description 5
- 229960002747 betacarotene Drugs 0.000 claims description 5
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims description 5
- 241001061264 Astragalus Species 0.000 claims description 4
- 235000006533 astragalus Nutrition 0.000 claims description 4
- 210000004233 talus Anatomy 0.000 claims description 4
- 239000000686 essence Substances 0.000 claims description 2
- 235000013376 functional food Nutrition 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 11
- 235000013305 food Nutrition 0.000 abstract description 5
- 230000005855 radiation Effects 0.000 abstract description 5
- 235000019156 vitamin B Nutrition 0.000 abstract description 4
- 239000011720 vitamin B Substances 0.000 abstract description 4
- 229940046001 vitamin b complex Drugs 0.000 abstract description 4
- 208000027418 Wounds and injury Diseases 0.000 abstract description 2
- 230000006378 damage Effects 0.000 abstract description 2
- 230000036541 health Effects 0.000 abstract description 2
- 208000014674 injury Diseases 0.000 abstract description 2
- 229940088594 vitamin Drugs 0.000 description 13
- 229930003231 vitamin Natural products 0.000 description 13
- 235000013343 vitamin Nutrition 0.000 description 13
- 239000011782 vitamin Substances 0.000 description 13
- 150000003722 vitamin derivatives Chemical class 0.000 description 12
- 230000006870 function Effects 0.000 description 11
- 206010016256 fatigue Diseases 0.000 description 10
- 239000000463 material Substances 0.000 description 6
- 240000003444 Paullinia cupana Species 0.000 description 4
- 235000000556 Paullinia cupana Nutrition 0.000 description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 244000269722 Thea sinensis Species 0.000 description 3
- FEZWOUWWJOYMLT-DSRCUDDDSA-M cobalt;[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,1 Chemical compound [Co].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FEZWOUWWJOYMLT-DSRCUDDDSA-M 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 208000003464 asthenopia Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000003507 refrigerant Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- 102000040350 B family Human genes 0.000 description 1
- 108091072128 B family Proteins 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 206010039796 Seborrhoeic keratosis Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 206010047571 Visual impairment Diseases 0.000 description 1
- 229930003537 Vitamin B3 Natural products 0.000 description 1
- 229930003571 Vitamin B5 Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000001785 acacia senegal l. willd gum Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000001800 adrenalinergic effect Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 235000019169 all-trans-retinol Nutrition 0.000 description 1
- 239000011717 all-trans-retinol Substances 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 210000000133 brain stem Anatomy 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000002079 cooperative effect Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 208000018685 gastrointestinal system disease Diseases 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000002434 immunopotentiative effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000000905 isomalt Substances 0.000 description 1
- 235000010439 isomalt Nutrition 0.000 description 1
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- BITYAPCSNKJESK-UHFFFAOYSA-N potassiosodium Chemical compound [Na].[K] BITYAPCSNKJESK-UHFFFAOYSA-N 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000022558 protein metabolic process Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 201000003385 seborrheic keratosis Diseases 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 208000029257 vision disease Diseases 0.000 description 1
- 230000004393 visual impairment Effects 0.000 description 1
- 235000019160 vitamin B3 Nutrition 0.000 description 1
- 239000011708 vitamin B3 Substances 0.000 description 1
- 235000009492 vitamin B5 Nutrition 0.000 description 1
- 239000011675 vitamin B5 Substances 0.000 description 1
- 235000020985 whole grains Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明涉及一种具有保护视力缓解疲劳功能的组合物及其制备方法和应用,属于食品领域。所述组合物包括木糖醇、抹茶粉、瓜拉纳提取物、黄芪提取物、清凉剂香精、β‑胡萝卜素、维生素B1、维生素B2、维生素B6、维生素B12、烟酸、泛酸、麦芽糊精。本发明所述抹茶粉中的儿抹茶精与维生素B族、β‑胡萝卜素的共同作用能够减少辐射、紫外线等外部刺激对眼部的伤害,同时,加强眼部细胞的自我修复能力,起到护眼保健的功效。
Description
技术领域
本发明涉及一种具有保护视力缓解疲劳功能的组合物及其制备方法和应用,属于食品领域。
背景技术
随着社会竞争压力的增大及电子产品的普及,视力下降、眼睛疲劳、眼睛干涩、角膜干燥、夜盲症等眼部不适已经成为学生、白领甚至每一个人都面临的问题,同时,长时间的学习工作压力会造成体力的透支,精神不振,影响效率。
目前,市面现有的提神醒脑产品或保护视力产品大多成分或功能单一,很难同时满足多种需要,有些提神功能的产品长期食用还会产生依赖性,不利于身体健康。
发明内容
本发明通过多成分组合物,使其具有多种功能,解决了上述问题。
本发明提供了一种具有保护视力缓解疲劳功能的组合物,所述组合物包括木糖醇、抹茶粉、瓜拉纳提取物、黄芪提取物、清凉剂香精、β-胡萝卜素、维生素B1、维生素B2、维生素B6、维生素B12、烟酸、泛酸、麦芽糊精。
本发明所述组合物优选为,按重量份,由下述组分组成:
本发明所述木糖醇具有能量低、甜度高、食用不产生蛀牙、代谢不需要胰岛素参与等优点。
本发明所述抹茶粉含丰富的维他命A原,抹茶中含有的儿抹茶精能够中和放射元素锶和减少原子辐射,具有保护视力及抗辐射的功效,同时,抹茶含咖啡碱,具有兴奋中枢神经、提神醒脑之效。
本发明所述瓜拉纳提取物的主要成分为咖啡因,同时,含有多种氨基酸、单宁酸、蛋白质、维生素、矿物质等,具有提神醒脑、恢复体力、补充能量、缓解疲劳等功效。
本发明所述黄芪提取物的主要成分为黄芪多糖,可作为免疫促进剂或调节剂,具有抗病毒、抗辐射、抗疲劳、抗应激、抗氧化等作用。
本发明所述β-胡萝卜素是一种天然色素,在动物体内可转化为维生素A,维生素A参与视素质的再生和合成,是构成眼感光材料的重要原料,补充β-胡萝卜素可治疗夜盲症、干眼病及上皮组织角化症。
维生素B族是推动体内代谢的重要成分,同时,对神经愉悦具有积极的促进作用;本发明所述维生素B1能够促进血液循环,辅助代谢,有助于人体感知,并使脑功能发挥至最佳状态,对能量代谢、生长、食欲、学习能力均起着积极的作用;本发明所述维生素B2能够促进红细胞形成,抗体制造,缓解眼睛疲劳,预防白内障,辅助糖类、脂肪、蛋白质代谢;本发明所述烟酸,又称为维生素B3,有助于促进消化系统健康,改善肠胃功能障碍和腹泻,有助于降低血液中胆固醇和甘油三酯水平;本发明所述泛酸,又称为维生素B5,有助于肾上腺素的产生,从而有效缓解压力和疲劳,本发明所述维生素B6有利于协助维持体内钠钾平衡,帮助脑和免疫系统发挥正常的生理机能,此外B6还可以活化体内的许多种酶,利于其它营养物质的吸收;本发明所述维生素B12可以消除烦躁,帮助集中注意力和增强记忆力;上述各B族维生素混合使用,具有协同增效作用。
本发明所述瓜拉纳提取物中咖啡因的含量优选为10-30wt%。
本发明所述黄芪提取物中黄芪多糖的含量优选为10-90wt%。
本发明另一目的为提供一种上述组合物的制备方法,所述制备方法为:按预定重量份,将各组分混匀,得到具有保护视力缓解疲劳功能的组合物。
本发明又一目的为提供一种上述组合物在功能性食品中的应用。
本发明所述应用方法优选为:所述组合物可直接冲服或加工成片剂、胶囊剂、固体饮料,也可作为功能性原料加入其它食品中。
本发明所述组合物可根据实际需要添加其它辅料制成其它剂型,所述辅料为山梨糖醇、异麦芽酮糖醇、赤藓糖醇、硬脂酸镁、可溶性淀粉、β-环糊精、阿拉伯胶中的一种或多种。
本发明有益效果为:
①本发明将木糖醇作为甜味剂,甜度好且食用不会造成龋齿、胰岛素升高等问题。
②本发明所述抹茶粉中的儿抹茶精与维生素B族、β-胡萝卜素的共同作用能够减少辐射、紫外线等外部刺激对眼部的伤害,同时,加强眼部细胞的自我修复能力,起到护眼保健的功效。
③本发明所述抹茶粉、瓜拉纳提取物、黄芪提取物的共同作用对于长时间伏案工作或学习的人群来说,具有提神醒脑、补充体力的协同功效,B族维生素能够刺激神经系统,使人心情愉悦,舒缓压力,提高记忆力,上述组分搭配具有协同增效的作用。
④本发明所述维生素B族是推动体内代谢的重要成分,各维生素间具有协同作用,本发明选用多种维生素B族成分,使用效果大于单一组分。
⑤本发明所述瓜拉纳提取物中的主要成分为咖啡因,其具有苦味,抹茶粉的茶香与清凉剂的清凉感可以掩盖瓜拉纳的苦味。
具体实施方式
下述非限制性实施例可以使本领域的普通技术人员更全面地理解本发明,但不以任何方式限制本发明。
下述抹茶粉购于绍兴御茶村茶业有限公司;
下述瓜拉纳提取物购于罗可兰食品配料(北京)有限公司,其咖啡因的含量为22wt%;
下述黄芪提取物购于陕西嘉禾植物化工有限责任公司,其黄芪多糖的含量为40wt%。
实施例1
一种具有保护视力缓解疲劳功能的组合物的制备方法,所述制备方法为:将6300g木糖醇、3000g抹茶粉、100g瓜拉纳提取物、300g黄芪提取物、200g清凉剂香精、1gβ-胡萝卜素、1.5g维生素B1、1.5g维生素B2、2g维生素B6、1mg维生素B12、10g烟酸、10g泛酸与75g麦芽糊精混匀,灌装,可直接冲服或作为功能性辅料加入到其它食品中。
实施例2
一种具有保护视力缓解疲劳功能的组合物的制备方法,所述制备方法为:将4700g木糖醇、4700g抹茶粉、200g瓜拉纳提取物、200g黄芪提取物、300g清凉剂香精、1gβ-胡萝卜素、2g维生素B1、2g维生素B2、2g维生素B6、1mg维生素B12、20g烟酸、20g泛酸与55g麦芽糊精混匀,灌装,可直接冲服或作为功能性辅料加入到其它食品中。
实施例3
一种具有保护视力缓解疲劳功能的组合物的制备方法,所述制备方法为:以40w/v%阿拉伯胶溶液作为粘合剂,采用常规湿法制粒方法将6700g木糖醇、2000g抹茶粉、1gβ-胡萝卜素进行混合制粒,干燥,整粒,再加入400g瓜拉纳提取物、500g黄芪提取物、200g清凉剂香精、2g维生素B1、2g维生素B2、4g维生素B6、1mg维生素B12、20g烟酸、20g泛酸、51g麦芽糊精与100g硬脂酸镁混匀,压制成片。
Claims (6)
1.一种具有保护视力缓解疲劳功能的组合物,其特征在于:所述组合物包括木糖醇、抹茶粉、瓜拉纳提取物、黄芪提取物、清凉剂香精、β-胡萝卜素、维生素B1、维生素B2、维生素B6、维生素B12、烟酸、泛酸、麦芽糊精。
2.根据权利要求1所述的组合物,其特征在于:所述组合物,按重量份,由下述组分组成:
3.根据权利要求2所述的组合物,其特征在于:所述瓜拉纳提取物中咖啡因的含量为10-30wt%。
4.根据权利要求3所述的组合物,其特征在于:所述黄芪提取物中黄芪多糖的含量为10-90wt%。
5.权利要求1、2、3或4所述组合物的制备方法,其特征在于:所述制备方法为:按预定重量份,将各组分混匀,得到具有保护视力缓解疲劳功能的组合物。
6.权利要求1、2、3或4所述组合物在功能性食品中的应用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710219002.3A CN106954854A (zh) | 2017-04-05 | 2017-04-05 | 一种具有保护视力缓解疲劳功能的组合物及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710219002.3A CN106954854A (zh) | 2017-04-05 | 2017-04-05 | 一种具有保护视力缓解疲劳功能的组合物及其制备方法和应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106954854A true CN106954854A (zh) | 2017-07-18 |
Family
ID=59483927
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710219002.3A Pending CN106954854A (zh) | 2017-04-05 | 2017-04-05 | 一种具有保护视力缓解疲劳功能的组合物及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106954854A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111053234A (zh) * | 2019-12-30 | 2020-04-24 | 广州市中食科康保健食品有限公司 | 一种用于缓解视力疲劳的保健食品及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102150724A (zh) * | 2011-03-30 | 2011-08-17 | 姜天安 | 一种提神缓解体力和视觉疲劳的功能性混合物及其应用 |
CN102726648A (zh) * | 2012-05-28 | 2012-10-17 | 北京康比特体育科技股份有限公司 | 一种低血糖指数的提神醒脑的组合物 |
CN103251054A (zh) * | 2013-05-31 | 2013-08-21 | 中国人民解放军海军医学研究所 | 一种抗疲劳保健食品组合物及其制备方法 |
-
2017
- 2017-04-05 CN CN201710219002.3A patent/CN106954854A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102150724A (zh) * | 2011-03-30 | 2011-08-17 | 姜天安 | 一种提神缓解体力和视觉疲劳的功能性混合物及其应用 |
CN102726648A (zh) * | 2012-05-28 | 2012-10-17 | 北京康比特体育科技股份有限公司 | 一种低血糖指数的提神醒脑的组合物 |
CN103251054A (zh) * | 2013-05-31 | 2013-08-21 | 中国人民解放军海军医学研究所 | 一种抗疲劳保健食品组合物及其制备方法 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111053234A (zh) * | 2019-12-30 | 2020-04-24 | 广州市中食科康保健食品有限公司 | 一种用于缓解视力疲劳的保健食品及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101574140B (zh) | 一种具有增强人体免疫功能和抗疲劳作用的饮品组合物 | |
EP1551239B1 (en) | Drink composition | |
CN101485445B (zh) | 保健食品 | |
CN102210474B (zh) | 一种护眼健脑泡腾片剂 | |
KR102396152B1 (ko) | 간편식 영양균형 건강식품 | |
CN107455625A (zh) | 一种具有抗疲劳减肥功能的植物营养素饮料及其制备工艺 | |
CN102550912B (zh) | 一种提神醒脑的组合物 | |
CN104432036A (zh) | 缓解视疲劳的保健营养组合物及其制备方法与应用 | |
CN105288578A (zh) | 一种具有缓解疲劳功能的制剂 | |
CN102048884B (zh) | 一种含瓜拉那提取物的减肥组合物 | |
CN106923130A (zh) | 含西红花的固体饮料、其制备方法及应用 | |
CN113317509B (zh) | 一种生酮营养代餐粉及其应用 | |
CN109363009A (zh) | 一种黄芪蓝莓组合物及由其制备的黄芪蓝莓饮料及其制备方法 | |
CN102726648B (zh) | 一种低血糖指数的提神醒脑的组合物 | |
CN104543274A (zh) | 一种含dha的软糖 | |
CN106954854A (zh) | 一种具有保护视力缓解疲劳功能的组合物及其制备方法和应用 | |
CN107998370B (zh) | 一种可增强机体运动能力且缓解运动疲劳的组合物 | |
CN102600303A (zh) | 以刺五加和西洋参为基础的抗疲劳组合物及其制备方法 | |
CN109673802A (zh) | 一种磷脂酰丝氨酸益智仁压片糖果及制备方法和应用 | |
CN110326776A (zh) | 一种适合航天员的提高免疫力的药食同源复合制剂 | |
CN109619189A (zh) | 一种沙棘黑果花楸护眼奶片及其制备方法 | |
CN104397719A (zh) | 玛咖片及其制备方法 | |
KR102324480B1 (ko) | 신선초를 함유하는 건강식품 | |
CN107439866A (zh) | 枸杞鹰嘴豆植物营养素饮料及其制备工艺 | |
CN106473124A (zh) | 一种促进婴幼儿智力发育的组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170718 |
|
RJ01 | Rejection of invention patent application after publication |